Neuren Pharmaceuticals reported AUD3.74M in Selling and Administration Expenses for its fiscal semester ending in December of 2025.





Selling And Administration Expenses Change Date
Akebia Therapeutics USD 23.53M 3.19M Dec/2025
Alaunos Therapeutics USD 424K 23K Jun/2026
Avita Medical AUD 19.54M 516K Jun/2026
Clinuvel Pharmaceuticals AUD 3.85M 5.27M Dec/2025
Dianthus Therapeutics USD 13.56M 1.09M Jun/2026
Genetic Signatures AUD 908K 31K Dec/2025
Ionis Pharmaceuticals USD 154M 23.92M Sep/2026
Medical Developments International AUD 2.84M 4.19M Dec/2025
Neuren Pharmaceuticals AUD 3.74M 2.5M Dec/2025
Organon & Co USD 407M 27M Sep/2026
PYC Therapeutics AUD 328.4K 1.8M Dec/2025
Starpharma Holdings AUD 4.42M 2.86M Dec/2025
Tectonic Therapeutic USD 6.17M 260K Jun/2026
Telix Pharmaceuticals AUD 107.02M 13.54M Jun/2026
Viatris USD 950.8M 183.7M Sep/2026
Xeris Pharmaceuticals USD 61.04M 7.89M Jun/2026